LEG Q1 2026 Earnings EPS Miss as Operational Challenges Weigh on Bottom Line Compass Therapeutics Q1 2026 Earnings Narrowed Loss and Positive Surprise as Pipeline Progress Continues REZI Q1 2026 Earnings EPS Beats Estimates Despite Revenue Uncertainty Stock Slides ED Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher PHR Q1 2026 Earnings EPS Beats Estimates by Wide Margin Stock Rises 2 CENT Q1 2026 Earnings Profitability Surprise Lifts Confidence Despite Flat Revenue Disclosure